A biosimilar (also known as follow-on biologic or subsequent entry biologic) is a biologic medical product that is almost an identical copy of an original product that is manufactured by a different company.

Cancer is a broad term used to describe a group of diseases characterized by the uncontrolled growth and spread of abnormal cells in the body.

Cochrane is a British international charitable organisation formed to synthesize medical research findings to facilitate evidence-based choices about health interventions involving health professionals, patients and policy makers.

The European Medicines Agency (EMA) is an agency of the European Union (EU) in charge of the evaluation and supervision of pharmaceutical products.

Glucose is a simple sugar and one of the most important sources of energy for living organisms.

As a medication, insulin is any pharmaceutical preparation of the protein hormone insulin that is used to treat high blood glucose.

Neutral Protamine Hagedorn (NPH) insulin, also known as isophane insulin, is an intermediate-acting insulin given to help control blood sugar levels in people with diabetes.

The WHO Model List of Essential Medicines (EM) is a list published by the World Health Organization (WHO) that identifies the most essential medications needed in a basic health care system.